| Literature DB >> 19541821 |
Matteo Bianchi1, Abdul Hakkim, Volker Brinkmann, Ulrich Siler, Reinhard A Seger, Arturo Zychlinsky, Janine Reichenbach.
Abstract
Chronic granulomatous disease (CGD) patients have impaired nicotinamide adenine dinucleotide phosphate (NADPH) oxidase function, resulting in poor antimicrobial activity of neutrophils, including the inability to generate neutrophil extracellular traps (NETs). Invasive aspergillosis is the leading cause of death in patients with CGD; it is unclear how neutrophils control Aspergillus species in healthy persons. The aim of this study was to determine whether gene therapy restores NET formation in CGD by complementation of NADPH oxidase function, and whether NETs have antimicrobial activity against Aspergillus nidulans. Here we show that reconstitution of NET formation by gene therapy in a patient with CGD restores neutrophil elimination of A nidulans conidia and hyphae and is associated with rapid cure of preexisting therapy refractory invasive pulmonary aspergillosis, underlining the role of functional NADPH oxidase in NET formation and antifungal activity.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19541821 PMCID: PMC2756123 DOI: 10.1182/blood-2009-05-221606
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113